Combined microwave therapy.
Fifty-two cases of advanced head and neck cancer were treated by 434-MHz radiowave hyperthermia which was combined with cobalt radiotherapy and/or radioactive gold grain implant. Complete resolution of primary and secondary lesions occurred in 94% of cases, and the survival rate after three years was 54%. Retrospective study of comparable series revealed 62.5% resolution rate, and 29% survival after treatment with hyperbaric oxygen and cobalt, while after conventional supervoltage therapy, the resolution rate was 36.5%, and only 19% survived for three years.
D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D006050:Gold Radioisotopes / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000628:therapy; D006801:Humans; D006931:Hyperbaric Oxygenation; D008872:Microwaves / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local; D011867:Radioisotope Teletherapy
D003037:Cobalt Radioisotopes; D006050:Gold Radioisotopes